These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22547371)

  • 1. Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.
    Fine JM; Baillargeon AM; Renner DB; Hoerster NS; Tokarev J; Colton S; Pelleg A; Andrews A; Sparley KA; Krogh KM; Frey WH; Hanson LR
    Exp Brain Res; 2012 Jun; 219(3):381-90. PubMed ID: 22547371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation.
    Fine JM; Renner DB; Forsberg AC; Cameron RA; Galick BT; Le C; Conway PM; Stroebel BM; Frey WH; Hanson LR
    Neurosci Lett; 2015 Jan; 584():362-7. PubMed ID: 25445365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease.
    Fine JM; Forsberg AC; Stroebel BM; Faltesek KA; Verden DR; Hamel KA; Raney EB; Crow JM; Haase LR; Knutzen KE; Kaczmarczek KD; Frey WH; Hanson LR
    J Neurol Sci; 2017 Sep; 380():164-171. PubMed ID: 28870559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement.
    Fine JM; Kosyakovsky J; Baillargeon AM; Tokarev JV; Cooner JM; Svitak AL; Faltesek KA; Frey WH; Hanson LR
    Brain Behav; 2020 Mar; 10(3):e01536. PubMed ID: 31960628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.
    Zhang XY; Cao JB; Zhang LM; Li YF; Mi WD
    J Neuroinflammation; 2015 Feb; 12():20. PubMed ID: 25644393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain.
    Guo C; Wang P; Zhong ML; Wang T; Huang XS; Li JY; Wang ZY
    Neurochem Int; 2013 Jan; 62(2):165-72. PubMed ID: 23262393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
    Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
    J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.
    Choi SH; Aid S; Caracciolo L; Minami SS; Niikura T; Matsuoka Y; Turner RS; Mattson MP; Bosetti F
    J Neurochem; 2013 Jan; 124(1):59-68. PubMed ID: 23083210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
    Farr AC; Xiong MP
    Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
    Hou Z; Nie C; Si Z; Ma Y
    Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
    Rockenstein E; Ubhi K; Trejo M; Mante M; Patrick C; Adame A; Novak P; Jech M; Doppler E; Moessler H; Masliah E
    BMC Neurosci; 2014 Jul; 15():90. PubMed ID: 25047000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram Alleviates Alzheimer's Disease-Type Tau Pathologies in the Aged P301L Tau Transgenic Mice.
    Wang YJ; Gong WG; Ren QG; Zhang ZJ
    J Alzheimers Dis; 2020; 77(2):807-819. PubMed ID: 32741828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.